Robert Garofalo1,2, Lisa M Kuhns1,2, Sari L Reisner3,4,5, Katie Biello5,6,7,8, Matthew J Mimiaga5,6,7,8,9. 1. Division of Adolescent Medicine, Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois. 2. Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 3. Division of General Pediatrics, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts. 4. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 5. The Fenway Institute, Fenway Health, Boston, Massachusetts. 6. Department of Behavioral and Social Health Sciences, Brown University School of Public Health, Providence, Rhode Island. 7. Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island. 8. Center for Health Equity Research, Brown University, Providence, Rhode Island. 9. Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Providence, Rhode Island.
Abstract
Importance: The incidence of HIV infection among transgender women in the United States is extremely high, with young transgender women (YTW) at highest risk; condomless sex is the primary risk behavior for transmission. However, there are no published randomized clinical trials to date examining interventions to reduce sexual risk for HIV acquisition and transmission within this group. Objective: To determine the efficacy of a culturally specific, empowerment-based, and group-delivered behavioral prevention intervention to reduce sexual risk for HIV acquisition and transmission in sexually active YTW aged 16 to 29 years. Design, Setting, and Participants: Randomized clinical efficacy trial of Project LifeSkills, a group-delivered, behavioral HIV prevention intervention, vs standard of care conducted among 190 sexually active YTW between March 26, 2012, and August 15, 2016, at community-based locations in Boston, Massachusetts, and Chicago, Illinois, to reduce sexual risk for HIV acquisition or transmission. Data analysis was by a modified intention-to-treat approach. Interventions: Participants were randomized (approximately 2:2:1) to the LifeSkills intervention (n = 116), standard of care only (n = 74), or a diet and nutrition time- and attention-matched control (attention control) arm (n = 43). The attention control arm was dropped during active enrollment per the Data Safety and Monitoring Board's recommendation. The LifeSkills intervention was delivered in six 2-hour sessions spanning a 3-week period. Main Outcomes and Measures: Primary outcome was change in the number of self-reported condomless anal or vaginal sex acts in the 4 months before the baseline assessment and that reported at the 4-, 8-, and 12-month visits. Results: Of the 190 study participants, the mean (SD) age was 23.4 (3.4) years (range, 16-29 years); 47 (24.7%) were white, 83 (43.7%) were black or African American, 25 (13.2%) were Hispanic or Latina, and 35 (18.4%) were another race/ethnicity. From baseline to 4 months, the LifeSkills group had a 30.8% greater mean (SE) reduction in condomless sex acts (2.26 [0.40] at baseline vs 1.22 [0.22] at 4 months) compared with the standard of care group (2.69 [0.59] at baseline vs 2.10 [0.47] at 4 months) (risk ratio [RR], 0.69; 95% CI, 0.60-0.80; P < .001). Similarly, the LifeSkills group had a 39.8% greater mean (SE) reduction in condomless sex acts at the 12-month follow-up visit compared with the standard of care group (0.71 [0.13] vs 1.40 [0.32]; RR, 0.60; 95% CI, 0.50-0.72; P < .001). Conclusions and Relevance: Among YTW at sexual risk of HIV acquisition or transmission, the LifeSkills intervention resulted in a 39.8% greater mean reduction in condomless sex acts during the 12-month follow-up in comparison to the standard of care group. This trial is the first to date to demonstrate evidence of efficacy for a behavioral intervention to reduce sexual risk in YTW. Trial Registration: ClinicalTrials.gov Identifier: NCT01575938.
RCT Entities:
Importance: The incidence of HIV infection among transgender women in the United States is extremely high, with young transgender women (YTW) at highest risk; condomless sex is the primary risk behavior for transmission. However, there are no published randomized clinical trials to date examining interventions to reduce sexual risk for HIV acquisition and transmission within this group. Objective: To determine the efficacy of a culturally specific, empowerment-based, and group-delivered behavioral prevention intervention to reduce sexual risk for HIV acquisition and transmission in sexually active YTW aged 16 to 29 years. Design, Setting, and Participants: Randomized clinical efficacy trial of Project LifeSkills, a group-delivered, behavioral HIV prevention intervention, vs standard of care conducted among 190 sexually active YTW between March 26, 2012, and August 15, 2016, at community-based locations in Boston, Massachusetts, and Chicago, Illinois, to reduce sexual risk for HIV acquisition or transmission. Data analysis was by a modified intention-to-treat approach. Interventions: Participants were randomized (approximately 2:2:1) to the LifeSkills intervention (n = 116), standard of care only (n = 74), or a diet and nutrition time- and attention-matched control (attention control) arm (n = 43). The attention control arm was dropped during active enrollment per the Data Safety and Monitoring Board's recommendation. The LifeSkills intervention was delivered in six 2-hour sessions spanning a 3-week period. Main Outcomes and Measures: Primary outcome was change in the number of self-reported condomless anal or vaginal sex acts in the 4 months before the baseline assessment and that reported at the 4-, 8-, and 12-month visits. Results: Of the 190 study participants, the mean (SD) age was 23.4 (3.4) years (range, 16-29 years); 47 (24.7%) were white, 83 (43.7%) were black or African American, 25 (13.2%) were Hispanic or Latina, and 35 (18.4%) were another race/ethnicity. From baseline to 4 months, the LifeSkills group had a 30.8% greater mean (SE) reduction in condomless sex acts (2.26 [0.40] at baseline vs 1.22 [0.22] at 4 months) compared with the standard of care group (2.69 [0.59] at baseline vs 2.10 [0.47] at 4 months) (risk ratio [RR], 0.69; 95% CI, 0.60-0.80; P < .001). Similarly, the LifeSkills group had a 39.8% greater mean (SE) reduction in condomless sex acts at the 12-month follow-up visit compared with the standard of care group (0.71 [0.13] vs 1.40 [0.32]; RR, 0.60; 95% CI, 0.50-0.72; P < .001). Conclusions and Relevance: Among YTW at sexual risk of HIV acquisition or transmission, the LifeSkills intervention resulted in a 39.8% greater mean reduction in condomless sex acts during the 12-month follow-up in comparison to the standard of care group. This trial is the first to date to demonstrate evidence of efficacy for a behavioral intervention to reduce sexual risk in YTW. Trial Registration: ClinicalTrials.gov Identifier: NCT01575938.
Authors: Susan P Buchbinder; David V Glidden; Albert Y Liu; Vanessa McMahan; Juan V Guanira; Kenneth H Mayer; Pedro Goicochea; Robert M Grant Journal: Lancet Infect Dis Date: 2014-03-07 Impact factor: 25.071
Authors: G R Donenberg; E Emerson; F B Bryant; H Wilson; E Weber-Shifrin Journal: J Am Acad Child Adolesc Psychiatry Date: 2001-06 Impact factor: 8.829
Authors: Robert Garofalo; Amy K Johnson; Lisa M Kuhns; Christopher Cotten; Heather Joseph; Andrew Margolis Journal: J Urban Health Date: 2012-06 Impact factor: 3.671
Authors: Stefan D Baral; Tonia Poteat; Susanne Strömdahl; Andrea L Wirtz; Thomas E Guadamuz; Chris Beyrer Journal: Lancet Infect Dis Date: 2012-12-21 Impact factor: 25.071
Authors: Catherine A Koss; Sybil G Hosek; Peter Bacchetti; Peter L Anderson; Albert Y Liu; Howard Horng; Leslie Z Benet; Karen Kuncze; Alexander Louie; Parya Saberi; Craig M Wilson; Monica Gandhi Journal: Clin Infect Dis Date: 2018-01-06 Impact factor: 9.079
Authors: Jeffrey D Schulden; Binwei Song; Alex Barros; Azul Mares-DelGrasso; Charles W Martin; Ramon Ramirez; Linney C Smith; Darrell P Wheeler; Alexandra M Oster; Patrick S Sullivan; James D Heffelfinger Journal: Public Health Rep Date: 2008 Nov-Dec Impact factor: 2.792
Authors: Carlos F Cáceres; Florence Koechlin; Pedro Goicochea; Papa-Salif Sow; Kevin R O'Reilly; Kenneth H Mayer; Peter Godfrey-Faussett Journal: J Int AIDS Soc Date: 2015-07-20 Impact factor: 5.396
Authors: Matthew J Mimiaga; Jaclyn M W Hughto; Katie B Biello; Christopher M Santostefano; Lisa M Kuhns; Sari L Reisner; Robert Garofalo Journal: J Acquir Immune Defic Syndr Date: 2019-06-01 Impact factor: 3.731
Authors: Pablo K Valente; Jordan D Dworkin; Curtis Dolezal; Anneliese A Singh; Allen J LeBlanc; Walter O Bockting Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2022-03-21 Impact factor: 4.328
Authors: Harry Jin; Arjee Restar; William C Goedel; Adedotun Ogunbajo; Katie Biello; Don Operario; Lisa Kuhns; Sari L Reisner; Robert Garofalo; Matthew J Mimiaga Journal: LGBT Health Date: 2020-09-04 Impact factor: 4.151
Authors: Carmen H Logie; David J Kinitz; Lesley Gittings; Yasmeen Persad; Ashley Lacombe-Duncan; Tonia Poteat Journal: Health Promot Int Date: 2022-06-23 Impact factor: 3.734
Authors: Scott D Rhodes; Lisa M Kuhns; Jasmine Alexander; Jorge Alonzo; Patricia A Bessler; Cari Courtenay-Quirk; Damian J Denson; Kaiji Evans; Carla A Galindo; Robert Garofalo; Deborah J Gelaude; Anna L Hotton; Amy K Johnson; Lilli Mann-Jackson; Abigail Muldoon; Reyna Ortiz; Josie Lynne Paul; Judy Perloff; Kevin Pleasant; Beth A Reboussin; Lucero Refugio Aviles; Eunyoung Y Song; Amanda E Tanner; Scott Trent Journal: AIDS Educ Prev Date: 2021-08